The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Open accessAbstract
We have generated a novel transgenic mouse model on a C57BL/6J genetic background that coexpresses KM670/671NL mutated amyloid precursor protein and L166P mutated presenilin 1 under the control of a neuron-specific Thy1 promoter element (APPPS1 mice). Cerebral amyloidosis starts at 6-8 weeks and the ratio of human amyloid (A)beta42 to Abeta40 is 1.5 and 5 in pre-depositing and amyloid-depositing mice, respectively. Consistent with this ratio, extensive congophilic parenchymal amyloid but minimal amyloid angiopathy is observed. Amyloid-associated pathologies include dystrophic synaptic boutons, hyperphosphorylated tau-positive neuritic structures and robust gliosis, with neocortical microglia number increasing threefold from 1 to 8 months of age. Global neocortical neuron loss is not apparent up to 8 months of age, but local neuron loss in the dentate gyrus is observed. Because of the early onset of amyloid lesions, the defined genetic background of the model and the facile breeding characteristics, APPPS1 mice are well suited for studying therapeutic strategies and the pathomechanism of amyloidosis by cross-breeding to other genetically engineered mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activated microglia surround amyloid plaques in the brains of both human patients with AD and mouse models of Aβ amyloidosis13,15,21,22.”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“although a previous report demonstrated no sex-dependent differences in Aβ accumulation in this APPPS1–21 mouse model13”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A previous report demonstrated no sex-dependent difference in the phenotypes of APP(Swe)/PS1(L166P) mice8.”
From Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reactive gliosis, encompassing microgliosis and astrogliosis, are prevalent neuropathological hallmarks observed in the brains of both human AD and mouse models of Aβ amyloidosis8,15,16.”
From Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because it has been known that there is no sex effect in this experimental group8, male and female mice were combined for statistical analyses.”
From Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sample sizes were chosen based on prior publications using the APP/PS1 and P301S mouse models, which provided estimations of expected effect sizes and variance.”
From APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints (2023) · cites this paper as Radde et al., 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The APPPS1-21 (APPPS1) mouse line coexpresses human amyloid precursor protein harboring the K670M/ N671L familial AD mutation and presenilin 1 harboring the L166P familial AD mutation, under the control of the neuron-specific Thy1 promoter.21”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APPPS1 mouse line coexpresses APP K670M/N671L and PS1 L166P mutations under the control of the neuronspecific Thy1 promoter and exhibits early and robust A deposition beginning at 6 -8 weeks of age in the cortex and 3-4 months of age in the hippocampus.21”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dozens of mouse lines overexpressing several combinations of APP and PSEN1 mutations have been created to accelerate the onset of Aβ pathologies in brains [28–30].”
From Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease (2019) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The APPPS1–21 mouse model used in our study starts to accumulate Aβ in the neocortex at approximately 6 to 8 weeks of age and exhibits robust Aβ accumulation and plaque deposition at 4 months of age13.”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Abnormal activation of microglia and astrocytes is observed in the brains of AD patients15 and APPPS1–21 transgenic model mice13.”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Amyloid-associated gliosis is consistently observed in the brains of AD patients15 and amyloidosis mouse models8,16.”
From Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis (2024) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“APPPS1-21 mice overexpress a human APP with a Swedish mutation (KM670/671NL) and mutant PS1 with the L166P mutation.”
From Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis (2011) · cites this paper as Radde et al., 2006
The cited source says what the claim attributes to it.
In the citing paper
“During submission of this manuscript, another study (Takalo et al. 2025), using the APP/PS1 model which develops an elevated Aβ42:40 (~5:1) (Radde et al. 2006), proposed that the protective variant reduced the number of plaques and overall plaque load”
From Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App NL ‐G‐F Mice (2026) · cites this paper as Radde et al. 2006
The cited source says what the claim attributes to it.
In the citing paper
“we mated Cx3cr1 knockout mice to two different mouse models of AD that exhibit either rapid deposition of primarily A42 (the APPPS1 model) 21 or gradual deposition of primarily A40 (the R1.40 model).[22][23][24]”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“The increased levels of CH25H mRNA and protein were also observed in the frontal cortex of 4-month-old APPPS1-21 mice bearing amyloid plaques [65] (Fig. 1c, d, e).”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [65]
In the citing paper
“the study utilized APP/PS1 and APP23 transgenic mouse models, both of which were generated through expression of mutated PS1 and/or APP under the neuron-specific Thy1 promoter element [151, 152].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [151]
In the citing paper
“The other major limitation of these mouse models was that while some showed evidence of localized hyperphosphylated tau that may represent “pretangles”[107, 118, 151, 159], none developed neurofibrillary tangles.”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citationHolcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 829
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 565
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease
Rouleau, I., Salmon, D. P., Butters, N., Kennedy, C. M., & McGuire, K. (1992) · Brain and Cognition · doi:10.1016/0278-2626(92)90112-y · Cited by 556
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,000
Kuhse, J., Groeneweg, F. L., Kins, S., Gorgas, K., Nawrotzki, R., Kirsch, J., & Kiss, É. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054623 · Cited by 17
Dikranian, K. T., Kim, J., Stewart, F. R., Levy, M. A., & Holtzman, D. M. (2012) · Europe PMC (PubMed Central) · Cited by 17
Fröhlich, C., Paarmann, K., Steffen, J., Stenzel, J., Krohn, M., Heinze, H., & Pahnke, J. (2013) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.3.2013.1.3 · Cited by 17
Vidal, R., Sammeta, N., Garringer, H. J., Sambamurti, K., Miravalle, L., Lamb, B. T., & Ghetti, B. F. (2012) · The FASEB Journal · doi:10.1096/fj.12-205542 · Cited by 17
Self-citationAnalysis of the vasculature by immunohistochemistry in paraffin-embedded brains
Decker, Y., Müller, A., Németh, E., Schulz‐Schaeffer, W., Fatar, M., Menger, M. D., Liu, Y., & Fassbender, K. C. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1595-8 · Cited by 17
Cicchetti, F., David, L. S., Siddu, A., & Denis, H. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104530 · Cited by 17
Jin, L., Pan, Y., Tran, N. L. L., Polychronopoulos, L. N., Warrier, A., Brouwer, K. L. R., & Nicolazzo, J. A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01227 · Cited by 17
Šoškić, V., Klemm, M., Proikas‐Cezanne, T., Schwall, G., Poznanović, S., Stegmann, W., Groebe, K., Zengerling, H., Schoepf, R., Burnet, M. W. M., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr700686x · Cited by 17
Ni, R., Deán‐Ben, X. L., Kirschenbaum, D. S., Rudin, M., Chen, Z., Crimi, A., Voigt, F. F., Nilsson, K. P. R., Helmchen, F., Nitsch, R. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.25.964064 · Cited by 17
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 16
Antoniou, A., Stavrou, M., Evripidou, N., Georgiou, E., Kousiappa, I., Koupparis, A. M., Papacostas, S., Kleopa, K. A., & Damianou, C. (2023) · Journal of Ultrasound · doi:10.1007/s40477-023-00805-4 · Cited by 16
Koller, E. J., Wood, C. A., Lai, Z., Borgenheimer, E., Hoffman, K. L., & Jankowsky, J. L. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03004-4 · Cited by 16
Alam, K., Nair, L. S., Mukherjee, S., Kaur, K., Singh, M., Kaity, S., Ravichandiran, V., Banerjee, S., & Roy, S. (2024) · Bio-Design and Manufacturing · doi:10.1007/s42242-024-00282-6 · Cited by 16
Saha, P., & Sisodia, S. S. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00426 · Cited by 16
Vulović, M., Divac, N., & Jakovčevski, I. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00011 · Cited by 16
Song, Z., Li, F., He, C., Yu, J., Li, P., Li, Z., Yang, M., & Cheng, S. (2020) · Aging · doi:10.18632/aging.104068 · Cited by 16
Lopez‐Picon, F. R., Keller, T., Bocancea, D. I., Helin, J. S., Krzyczmonik, A., Helin, S., Damont, A., Dollé, F., Rinne, J. O., Haaparanta‐Solin, M., et al. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01646-5 · Cited by 16
Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
Bascuñana, P., Brackhan, M., Möhle, L., Wu, J., Brüning, T., Eiriz, I., Jansone, B., & Pahnke, J. (2023) · Biomolecules · doi:10.3390/biom13020331 · Cited by 16
van Etten, E. S., Mahinrad, S., Grill, J. D., Salloway, S., Atri, A., Cogswell, P. M., Benzinger, T. L. S., Iwatsubo, T., Iadecola, C., Lemere, C. A., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71361 · Cited by 16
Srinivasan, S., Kancheva, D., Ren, S. D., Saito, T., Jans, M., Boone, F., Vandendriessche, C., Paesmans, I., Maurin, H., Vandenbroucke, R. E., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1323409 · Cited by 16
Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease
Fainstein, N., Dori, D., Frid, K., Fritz, A. T., Shapiro, I., Gabizon, R., & Ben‐Hur, T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00510 · Cited by 15
Pineau, H., & Sim, V. L. (2020) · Biomolecules · doi:10.3390/biom10071079 · Cited by 15
Liu, J., Hou, Z., Wu, J., Liu, K., Li, D., Gao, T., Liu, W., An, B., Sun, Y., Mo, F., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13085 · Cited by 18
Mestdagh, C. F. D. V., Koopmans, F., Breiter, J. C., Timmerman, J. A., Vogelaar, P. C., Krenning, G., Mansvelder, H. D., Smit, A. B., Henning, R. H., & van Kesteren, R. E. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01127-z · Cited by 15
Spitznagel, B. D., Buchanan, R. A., Consoli, D. C., Thibert, M., Bowman, A. B., Nobis, W. P., & Harrison, F. E. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.01.002 · Cited by 15
Colavitta, M. F., Grasso, L., & Barrantes, F. J. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.5 · Cited by 15
Plaque vicinity as a hotspot of microglial turnover in a mouse model of Alzheimer's disease
Olmedillas, M., Brawek, B., Li, K., Richter, C., & Garaschuk, O. (2023) · Glia · doi:10.1002/glia.24458 · Cited by 15
Bianchi, F. T., Camera, P., Ala, U., Imperiale, D., Migheli, A., Boda, E., Tempia, F., Berto, G. E., Bosio, Y., Oddo, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022370 · Cited by 15
Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice
Mahler, J., Morales‐Corraliza, J., Stolz, J., Skodras, A., Radde, R., Duma, C. C., Eisele, Y. S., Mazzella, M. J., Wong, H. K. A., Klunk, W. E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.011 · Cited by 15
Self-citationTelencephalic neurocircuitry and synaptic plasticity in rodent spatial learning and memory
Pooters, T., der Jeugd, A. V., Callaerts‐Vegh, Z., & D’Hooge, R. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.015 · Cited by 15
Label-free multiphoton imaging of β-amyloid plaques in Alzheimer’s disease mouse models
Wang, S., Lin, B., Lin, G., Sun, C., Lin, R., Huang, J., Tao, J., Wang, X., Wu, Y., Chen, L., et al. (2019) · Neurophotonics · doi:10.1117/1.nph.6.4.045008 · Cited by 15
Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Shafi, S., Singh, A., Ibrahim, A. M., Alhajri, N., Izneid, T. A., & Pottoo, F. H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15215 · Cited by 15
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15
Stallings, N. R., O’Neal, M. A., Hu, J., Shen, Z., & Malter, J. S. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01323-5 · Cited by 14
Kiss, É., Kins, S., Gorgas, K., Szakács, K. H. V., Kirsch, J., & Kuhse, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084165 · Cited by 14
Zhou, L., Wang, N., Feng, W., Liu, X., Wu, Q., Chen, J., Jiao, X., Ning, X., Qi, Z., Xu, Z., et al. (2024) · Glia · doi:10.1002/glia.24606 · Cited by 14
Dongre, P., Ramesh, M., Govindaraju, T., & Inamdar, M. S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03415-5 · Cited by 14
Anti-Amyloid-β Immunotherapy for Alzheimer’s Disease
Crehan, H., & Lemere, C. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00007-1 · Cited by 14
Li, C., Meng, P., Zhang, B.-Z., Kang, H., Wen, H.-L., Schluesener, H. J., Cao, Z., & Zhang, Z. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.32.20180021 · Cited by 14
Wiglenda, T., Groenke, N., Hoffmann, W., Manz, C., Diez, L., Buntru, A., Brusendorf, L., Neuendorf, N., Schnoegl, S., Haenig, C., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.033 · Cited by 14
Kartalou, G.-I., Endres, T., Leßmann, V., & Gottmann, K. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108797 · Cited by 14
Parekh, P. A., Mu, Q., Badachhape, A., Bhavane, R. C., Srivastava, M., Devkota, L., Sun, X., Bhandari, P., Eriksen, J. L., Tanifum, E. A., et al. (2022) · Theranostics · doi:10.7150/thno.72258 · Cited by 14
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14
Detection of Alzheimer’s disease amyloid-beta plaque deposition by deep brain impedance profiling
Béduer, A., Joris, P., Mosser, S., Fraering, P. C., & Renaud, P. (2015) · Journal of Neural Engineering · doi:10.1088/1741-2560/12/2/024001 · Cited by 14
Scheibe, S., Dorostkar, M. M., Seebacher, C., Uhl, R., Lison, F., & Herms, J. W. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.06.013 · Cited by 14
Xinze, S., Wei, X., Longze, 沙. S., & Xu, Q. (2018) · Chinese Medical Sciences Journal · doi:10.24920/03476 · Cited by 14
den Broeck, L. V., Sierksma, A. S. R., Hansquine, P., Thonnard, D., Callaerts‐Vegh, Z., & D’Hooge, R. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12695 · Cited by 14
Brackhan, M., Calza, G., Lundgren, K., Bascuñana, P., Brüning, T., Soliymani, R., Kumar, R., Abelein, A., Baumann, M., Lalowski, M. M., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154405 · Cited by 14
Tok, S., Maurin, H., Delay, C., Crauwels, D., Manyakov, N. V., der Elst, W. V., Moechars, D., & Drinkenburg, W. H. I. M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01393-w · Cited by 14
Modeling tau pathology in human stem cell derived neurons
Wray, S. (2017) · Brain Pathology · doi:10.1111/bpa.12521 · Cited by 14
He, P., Xin, W., Schulz, P., & Sierks, M. R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1597-z · Cited by 14
King, M. W., Jacob, S. M., Sharma, A., Lawrence, J. H., & Musiek, E. S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70885 · Cited by 13
Cai, J., Xie, D., Kong, F., Zhai, Z., Zhu, Z., Zhao, Y., Xu, Y., & Sun, T. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231249 · Cited by 13
Brandão, W. N., Jain, N., Yin, Z., Kleemann, K. L., Carpenter, M., Bao, X., Serrano, J. R., Tycksen, E., Durão, A. C. C. D. S., Barry, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3690 · Cited by 13
Paganetti, P., Antoniello, K., Devraj, K., Toni, N., Kieran, D., Madani, R., Pihlgren, M., Adolfsson, O., Froestl, W., Schrattenholz, A. S., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131091 · Cited by 13
Bastrup, J., Kastaniegaard, K., Asuni, A. A., Volbracht, C., & Stensballe, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190652 · Cited by 13
Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
Lin, T., Tjernberg, L. O., & Schedin‐Weiss, S. (2021) · Biomedicines · doi:10.3390/biomedicines9070801 · Cited by 13
Taxier, L. R., Philippi, S. M., York, J. M., LaDu, M. J., & Frick, K. M. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105124 · Cited by 13
Njavro, J. R., Vukicevic, M., Fiorini, E., Dinkel, L., Müller, S. A., Berghofer, A., Bordier, C., Kozlov, S. O., Halle, A., Buschmann, K., et al. (2022) · Cells · doi:10.3390/cells12010079 · Cited by 13
Gaunt, J. R., Zainolabidin, N., Yip, A. K. K., Tan, J. M., Low, A. Y. T., Chen, A. I., & Ch’ng, T. H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02913-8 · Cited by 12
Crociara, P., Parolisi, R., Conte, D., Fumagalli, M., & Bonfanti, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063258 · Cited by 13
Zhang, Y., Wang, G., Wang, L., Zhao, J., Huang, R., & Xiong, Q. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1463944 · Cited by 13
Amyloidosis causes downregulation of SorLA, SorCS1 and SorCS3 expression in mice
Hermey, G., Hoffmeister‐Ullerich, S., Merz, B., Groß, D., Kuhl, D., & Kins, S. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0146 · Cited by 13
Kiss, É., Kins, S., Gorgas, K., Orlik, M., Fischer, C., Endres, K., Schlicksupp, A., Kirsch, J., & Kuhse, J. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0153 · Cited by 13
Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer’s Disease
Gherardelli, C., Cisternas, P., Vera-Salazar, R. F., Méndez‐Orellana, C., & Inestrosa, N. C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215273 · Cited by 13
Thygesen, C., Metaxas, A., Larsen, M. R., & Finsen, B. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180197 · Cited by 13
MicroRNA Profiling in Aging Brain of PSEN1/PSEN2 Double Knockout Mice
Ham, S., Kim, T. K., Lee, S., Tang, Y.-P., & Im, H.-I. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0753-6 · Cited by 12
Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice
Salas, I. H., Callaerts-Vegh, Z., D’Hooge, R., Saido, T. C., Dotti, C. G., & De Strooper, B. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180410 · Cited by 12
Kasica, N. P., Zhou, X., Jester, H. M., Holland, C. E., Ryazanov, A. G., Forshaw, T. E., Furdui, C. M., & Ma, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.959326 · Cited by 12
Wang, W., Myers, S. J., Ollen‐Bittle, N., & Whitehead, S. N. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106798 · Cited by 12
Steeland, S., & Vandenbroucke, R. E. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.247443 · Cited by 12
Fulopova, B., Stuart, K. E., Bennett, W. R., Bindoff, A. D., King, A. E., Vickers, J. C., & Canty, A. J. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.25060 · Cited by 12
Clement, A., Madsen, M. J., Kastaniegaard, K., Wiborg, O., Asuni, A. A., & Stensballe, A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220064 · Cited by 12
Rotaru-Zăvăleanu, A. D., Neacșu, A. I., Neacsu, A., Pirici, D. N., Osiac, E., Cătălin, B., & Gheonea, D. I. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44090262 · Cited by 12
ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer’s Disease
Möhle, L., Stefan, K., Bascuñana, P., Brackhan, M., Brüning, T., Eiriz, I., Menuawy, A. E., van Genderen, S., Santos‐García, I., Górska, A. M., et al. (2023) · Biology · doi:10.3390/biology12070932 · Cited by 12
Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer’s Disease
Yang, E., Wang, J., Woodie, L. N., Greene, M. W., & Kaddoumi, A. (2023) · Molecules · doi:10.3390/molecules28145592 · Cited by 12
Chourrout, M., Sandt, C., Weitkamp, T., Dučić, T., Meyronet, D., Baron, T., Klohs, J., Rama, N., Boutin, H., Singh, S., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.07.046 · Cited by 12
Mammalian Models in Alzheimer’s Research: An Update
Sharma, H., Chang, K., Hulme, J., & An, S. S. A. (2023) · Cells · doi:10.3390/cells12202459 · Cited by 12
Shaik, S. M., Cao, Y., Gogola, J. V., Dodiya, H. B., Zhang, X., Boutej, H., Han, W., Križ, J., & Sisodia, S. S. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00668-7 · Cited by 12
Thakur, P., Baraskar, K., Shrivastava, V. K., & Medhi, B. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149176 · Cited by 12
Dominguez, S., Rodríguez, G., Fazelinia, H., Ding, H., Spruce, L. A., Seeholzer, S. H., & Dong, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191009 · Cited by 12
Alzghool, O. M., Rokka, J., Lopez‐Picon, F. R., Snellman, A., Helin, J. S., Okamura, N., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108676 · Cited by 12
Menuawy, A. E., Brüning, T., Eiriz, I., Hähnel, U., Marthe, F., Möhle, L., Górska, A. M., Santos‐García, I., Wangensteen, H., Wu, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021301 · Cited by 11
Haessler, A., Candlish, M., Hefendehl, J. K., Jung, N., & Windbergs, M. (2024) · Communications Biology · doi:10.1038/s42003-024-07182-6 · Cited by 10
Sarti, G., Traini, C., Magni, G., Attorre, S., Tognozzi, G., Calussi, E., Giovannini, M. G., Vannucchi, M. G., & Lana, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1596469 · Cited by 11
Feng, L., Wang, G., Song, Q., Feng, X., Su, J., Ji, G., & Li, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01330-3 · Cited by 11
Lo, A. C., Tesseur, I. C., Scopes, D. I. C., Nerou, E., Callaerts‐Vegh, Z., Vermaercke, B., Treherne, J. M., Strooper, B. D., & D’Hooge, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.030 · Cited by 11
Drummond, E., Muhling, J., Martins, R. N., Wijaya, L. K., Ehlert, E., & Harvey, A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059166 · Cited by 11
Duszczyk, M., Kuszczyk, M. A., Guridi, M., Łazarewicz, J. W., & Sadowski, M. J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.017 · Cited by 11
Wang, S., Yu, Y., Geng, S., Wang, D., Zhang, L., Xie, X., Wu, B., Li, C., Xu, H., Li, X., et al. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt256 · Cited by 11
Beyer, F., Agrelo, I. S., & Küry, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020455 · Cited by 11
He, P., Schulz, P., & Sierks, M. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015327 · Cited by 11
Loïodice, S., Drinkenburg, W. H. I. M., Ahnaou, A., McCarthy, A. P., Viardot, G., Cayre, E., Rion, B., Bertaina‐Anglade, V., Mano, M., L’Hostis, P., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01371-1 · Cited by 11
Cuadrado‐Tejedor, M., Pérez-González, M., Alfaro‐Ruiz, R., Badesso, S., Sucunza, D., Espelosin, M., Ursúa, S., Lachén‐Montes, M., Fernández‐Irigoyen, J., Santamaría, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111950 · Cited by 11
Steffen, J., Stenzel, J., Ibrahim, S. M., & Pahnke, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180395 · Cited by 11
Amyloid β perturbs elevated heme flux induced with neuronal development
Vidal, C., Daescu, K., FitzGerald, K. E., Starokadomska, A., Борисович, Б. И., & Li, Z. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.12.003 · Cited by 11
Schneeberger, S., Kim, S. J., Eede, P., Boltengagen, A., Braeuning, C., Andreadou, M., Becher, B., Karaiskos, N., Kocks, C., Rajewsky, N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.25.441313 · Cited by 11
The role of AMPKα subunit in Alzheimer's disease: In-depth analysis and future prospects
Xia, L., Chen, J., Huang, J., Lin, X., Jiang, J., Liu, T., Huang, N., & Luo, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34254 · Cited by 10
Mishra, R., & Upadhyay, A. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05668-y · Cited by 11
Vega, M., Hansen, H. H., Jensen, C. S., Alexiou, E., Madsen, M. R., Wichern, F., Kristiansen, M. S., Skytte, J. L., Salinas, C. G., Sotty, F., et al. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00737-7 · Cited by 10
Metadata
- Authors
- Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., Haass, C., Ghetti, B., Czech, C., Hölscher, C., Mathews, P. M., & Jucker, M.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- University of Basel (CH)
- University of Tübingen (DE)
- University of Ulster (GB)
- Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
- Indiana University School of Medicine (US)
- F. Hoffmann-La Roche AG (CH)
- New York University (US)
- Corresponding author
- Jucker, Mathias
- ORCID
- Venue
- The EMBO Reports
- Published
- 2006-08-11
- Volume
- 7
- Issue
- 9
- Pages
- 940-946
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1559665
- OpenAlex
- W2156788921
- Cited by
- 986
- References
- 32
- Citations by year
- 2026: 33 · 2025: 60 · 2024: 75 · 2023: 85 · 2022: 73 · 2021: 86 · 2020: 93 · 2019: 79 · 2018: 58 · 2017: 41 · 2016: 46 · 2015: 41 · 2014: 36 · 2013: 50 · 2012: 37
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission (LSHM-CT-2003-503330)
- Boehringer Ingelheim Stiftung
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- cerebral amyloidosis, amyloid-beta 42, amyloid angiopathy, tau hyperphosphorylation, gliosis, microglia, Alzheimer's disease model
- MeSH terms
- Animals, Cognition, Disease Models, Animal, Inflammation, Male, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Cerebral Amyloid Angiopathy, Neocortex, Mice, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
